Primer: BeOne Medicines (6160 HK) - Aug 2026
BeOne Medicines is rapidly transitioning into a commercial-stage global oncology powerhouse, driven by the strong performance of its flagship...
107 Views
Primer: BeOne (ONC US) - Aug 2026
BeOne is rapidly transitioning into a profitable, commercial-stage biopharmaceutical company, driven by the blockbuster success of its BTK...
119 Views